A study conducted by scientists at the Weizmann Institute of Science in Tel Aviv indicates that sildenafil, commonly known by the brand name Viagra, may have applications beyond its traditional use for erectile dysfunction. Originally developed to improve blood flow, the drug is now being investigated for its potential to curb cancer metastasis.

According to the research team, sildenafil appears to influence a biological mechanism related to the drug's known ability to dilate blood vessels. By affecting this process, the medication may limit the capacity of cancer cells to spread throughout the body. While the initial findings are described as promising, the report notes that this is an early-stage discovery regarding the drug's secondary effects. The research focuses specifically on the drug’s interaction with the body’s circulatory mechanisms and how those interactions might be repurposed to impede the progression of malignant tumors. Further clinical research will be required to determine if these laboratory findings can be safely and effectively translated into human cancer treatments.